Skip to content
10-K

Annual Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-20-004054

← back to feed
Filed
Apr 14, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Apr 14, 2020 78.7M sh
Current Liabilities FY 2019 · Dec 31, 2019 $2.27M
Current Liabilities FY 2019 · Dec 31, 2018 $2.09M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$257.92K
Total Liabilities FY 2019 · Dec 31, 2018 $2.09M
Current Assets FY 2019 · Dec 31, 2018 $359.79K
Total Assets FY 2019 · Dec 31, 2018 $581.79K
Sga Expense FY 2019 · Dec 31, 2018 $75.36K
Net Income FY 2019 · Dec 31, 2018 −$736.85K
Operating Income FY 2019 · Dec 31, 2018 −$235.88K
Revenue FY 2019 · Dec 31, 2018 $0
Cash And Equivalents FY 2019 · Dec 31, 2017 $460.11K
Stockholders Equity FY 2019 · Dec 31, 2017 −$749.55K